Binding of [3H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord

European Journal of Pharmacology

Volumn 633, Issue 1-3, 2010, Pages 15-23

  Bianchi, Bruce R ^a   El Kouhen, Rachid ^a   Chen, Jun ^a   Puttfarcken, Pamela S ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Dorsal root ganglia; Ligand gated ion channel; Resiniferatoxin; Spinal cord; TRPV1; Vanilloid

Indexed keywords

1 (5 ISOQUINOLINYL) 3 [4 (TRIFLUOROMETHYL)BENZYL]UREA; 1 (5 TERT BUTYL INDAN 1 YL) 3 ISOQUINOLIN 5 YL UREA; 1 (TERT BUTYL INDAN 1 YL) 3 ISOQUINOLIN 5 YL UREA; 1 ISOQUINOLIN 5 YL 3 (4 TRIFLUOROMETHYLBENZYL)UREA; 3' TRIFLUOROMETHYL 3,6 DIHYDRO 2H [1,2']BIPYRIDINYL 4 CARBOXYLIC ACID (4 TRIFLUOROMETHANESULFONYLPHENYL)AMIDE; A 778316; A 778317; A 784168; CALCIUM ION; CAPSAICIN; CAPSAZEPINE; NEUROTOXIN; OLVANIL; RADIOLIGAND; RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; RESINIFERATOXIN; TINYATOXIN; TRITIUM; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM TRANSPORT; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL GANGLION;

ANIMALS; CALCIUM; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CELL LINE, TRANSFORMED; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; ISOQUINOLINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SPINAL CORD; TRPV CATION CHANNELS; UREA;

EID: 77949914066     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.004     Document Type: Article

References (39)

1. Ahern G.P. Activation of TRPV1 by the satiety factor oleoylethanolamide. J. Biol. Chem. 2003, 278:30429-30434.
2. Bianchi B.R., Lee C.-H., Jarvis M.F., El Kouhen R., Moreland R.B., Faltynek C.R., Puttfarcken P.S. Modulation of human TRPV1 receptor activity by extracellular protons and host cell expression system. Eur. J. Pharmacol. 2006, 537:20-30.
3. 3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the transient receptor potential vanilloid-1 (TRPV1) receptor. J. Pharmacol. Exp. Ther. 2007, 323:285-293.
4. Bianchi B.R., Moreland R.B., Faltynek C.R., Chen J. Application of large-scale transiently transfected cells to functional assays of ion channels: different targets and assay formats. Assay Drug Dev. Tech. 2007, 5:417-424.
5. Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 2001, 24:487-517.
6. i) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
7. Chou M.Z., Mtui T., Gao Y.D., Kohler M., Middleton R.E. Resiniferatoxin binds to the capsaicin receptor (TRPV1) near the extracellular side of the S4 transmembrane domain. Biochemistry 2004, 43:2501-2511.
8. Chu C.J., Huang S.M., De Petrocellis L., Bisogno T., Ewing S.A., Miller J.D., Zipkin R.E., Daddario N., Appendino G., Di Marzo V., Walker J.M. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem. 2003, 278:13633-13639.
9. Cui M., Honore P., Zhong C., Gauvin D., Mikusa J., Hernandez G., Chandran P., Gomtsyan A., Brown B., Bayburt E.K., Marsh K., Bianchi B., McDonald H., Niforatos W., Neelands T.R., Moreland R.B., Decker M., Lee C.H., Sullivan J.P., Faltynek C.R. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J. Neurosci. 2006, 26:9385-9393.
10. El Kouhen R., Surowy C.S., Bianchi B.R., Neelands T.R., McDonald H.A., Niforatos W., Gomtsyan A., Lee C.-H., Honore P., Sullivan J.P., Jarvis M.F., Faltynek C.R. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid. J. Pharmacol. Exp. Ther. 2005, 314:400-409.
11. Gavva N.R., Klionsky L., Qu Y., Shi L., Tamir R., Edenson S., Zhang T.J., Viswanadhan V.N., Toth A., Pearce L.V., Vanderah T.W., Porreca F., Blumberg P.M., Lile J., Sun Y., Wild K., Louis J.C., Treanor J.J.S. Molecular determinants of vanilloid sensitivity in TRPV1. J. Biol. Chem. 2004, 279:20283-20295.
12. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8400-8405.
13. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., Cho S., Min K.H., Suh Y.G., Kim D., Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6155-6160.
14. Jordt S.E., Julius D. Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 2002, 108:421-430.
15. Jordt S.E., Tominaga M., Julius D. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8134-8139.
16. Julius D., Basbaum A. Molecular mechanisms of nociception. Nature 2001, 413:203-210.
17. Kym P.R., Kort M.E., Hutchins C.W. Analgesic potential of TRPV1 antagonists. Biochem. Pharmacol. 2009, 78:211-216.
18. Latorre R., Brauchi S., Orta G., Zaelzer C., Vargas G. ThermoTRP channels as modular proteins with allosteric gating. Cell Calcium 2007, 42:427-438.
19. Liapi A., Wood J.N. Extensive co-localization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult cerebral cortex. Eur. J. Neurosci. 2005, 22:825-834.
20. Lu G., Henderson D., Liu L., Reinhart P.H., Simon S.A. TRPV1b, a functional human vanilloid receptor splice variant. Mol. Pharmacol. 2005, 67:1119-1127.
21. Liu M., Huang W., Wu D., Priestley J.V. TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors. Eur. J. Neurosci. 2006, 24:1-6.
22. Matta J.A., Miyares R.L., Ahern G.P. TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. J. Physiol. 2007, 578:397-411.
23. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Gu A., Blumberg P.M., Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3655-3660.
24. Movahed P., Jönsson B.A., Birnir B., Wingstrand J.A., Jørgensen T.D., Ermund A., Sterner O., Zygmunt P.M., Högestätt E.D. Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J. Biol. Chem. 2005, 280:38496-38504.
25. Rutter A.R., Ma Q.P., Leveridge M., Bonnert T.P. Heteromerization and colocalization of TrpV1 and TrpV2 in mammalian cell lines and rat dorsal root ganglia. NeuroReport 2005, 16:1735-1739.
26. Ryu S., Liu B., Yao J., Fu Q., Qin F. Uncoupling proton activation of vanilloid receptor TRPV1. J. Neurosci. 2007, 27:12797-12807.
27. Sanchez J.F., Krause J.E., Cortright D.N. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat. Neuroscience 2001, 107:373-381.
28. Schumacher M.A., Moff I., Sudanagunta S.P., Levine J.D. Molecular cloning of an N-terminal splice variant of the capsaicin receptor. J. Biol. Chem. 2000, 275:2756-2762.
29. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 2000, 129:227-230.
30. Suzuki M., Sato J., Kutsuwada K., Ooki G., Masashi I. Cloning of a stretch-inhibitable nonselective cation channel. J. Biol. Chem. 1999, 274:6330-6335.
31. Szallasi A., Blumberg P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 1999, 51:159-212.
32. Szallasi A., Blumberg P.M., Annicelli L.L., Krause J.E., Cortright D.N. The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol. Pharmacol. 1999, 56:581-587.
33. Tillman T.S., Cascio M. Effects of membrane lipids on ion channel structure and function. Cell Biochem. Biophys. 2003, 38:161-190.
34. Valtschanoff J.G., Rustioni A., Guo A., Hwang S.J. Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. J. Comp. Neurol. 2001, 436:225-235.
35. Vellani V., Mapplebeck S., Moriondo A., Davis J.B., McNaughton P.A. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol. 2001, 534.3:813-825.
36. Vos M., Neelands T.R., McDonald H.A., Choi W., Kroger P.E., Puttfarcken P.S., Faltynek C.R., Moreland R.B., Han P. TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells. J. Neurochem. 2006, 99:1088-1102.
37. Wahl P., Foged C., Tullin S., Thomsen C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol. Pharmacol. 2001, 59:9-15.
38. Wang X., Miyares R.L., Ahern G.P. Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J. Physiol. 2005, 564:541-547.
39. Xue Q., Yu Y., Trilk S.L., Jong B.E., Schumacher M.A. The genomic organization of the gene encoding the vanilloid receptor: evidence for multiple splice variants. Genomics 2001, 76:14-20.